ReviewMetabolites2023

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives.

Georgiana-Diana Cazac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.